- DIAGNOS (ADK) forms a pilot proposal with Opticalia in Spain
- The councillor for Health in the Aspe City Council stressed that this initiative will produce important data concerning eye health for all Aspenses
- Opticalia Aspe is investing, on its own initiative, six thousand euros in this campaign to detect and stop preventable blindness
- Opticalia was founded as a great image group 10 years ago in Spain
- DIAGNOS is a publicly-traded Canadian corporation dedicated to the early detection of critical health problems based on its FLAIRE AI platform
- Diagnos Inc. (ADK) is down 1.82 per cent and is trading at C$0.54 at 12:49 pm ET
Diagnos Inc. (ADK) signs a pilot in Spain with three franchisees from Opticalia Group.
“A smart retinography is also used which, once the patient is positioned, automatically searches for the retina in the eye. All the techniques used in this process are non-invasive, painless and quick for the comfort and tranquillity of the patient,” states Elsa Tortosa, owner and head of optometrists in Opticalia franchise in Pinoso, Spain.
Santos Díaz, head of optometrists and owner of Opticalia franchises in the cities of Aspe and Novelda says,
“The campaign begins with the request for a previous appointment through the web or at the optician itself, where patients will register in the order of arrival and a free retinography will be carried out.”
The councillor for Health in the Aspe City Council, Yolanda Moreno, stressed that this initiative will produce important data concerning eye health for all Aspenses.
“Thanks to Opticalia Aspe our neighbours will be able to benefit from a treatment pre-diagnosis that allows detection of visual problems in a timely manner,” said Moreno.
Opticalia Aspe is investing, on its own initiative, six thousand euros in this campaign to detect and stop preventable blindness.
“One of the tools used in this diagnostic process is based on artificial intelligence, a resource that comes from DIAGNOS, an international company located in Canada with extensive experience and with more than 400 thousand retinographies performed around the world, “said Andre Larente, President of DIAGNOS
“This allows the precision of diabetic retinopathy pre-diagnoses to be very high, reaching a Sensitivity of 98.4 per cent, Specificity of 97.6 per cent and a certainty of 97.9 per cent,” added Larente.
Opticalia was founded as a great image group 10 years ago in Spain. Our goal is to group independent opticians who, while maintaining their personality, benefit from the advantages generated by belonging to a recognized brand.
DIAGNOS is a Canadian corporation dedicated to the early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform.
Diagnos Inc. (ADK) is down 1.82 per cent and is trading at C$0.54 at 12:49 pm ET.
